News
Q2 2025 Earnings Call Transcript August 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...
It's common for clinical-stage biotech companies to post net losses, but the market wasn't forgiving of this one's latest.
SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding ...
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating ...
Zacks Investment Research on MSN2d
Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is ...
SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Tuesday reported a loss of $171.9 million in its second quarter. On a per-share basis, the Salt Lake City-based ...
A complete guide on how to watch the Bleach anime in order, including whether the movies are canon and if there are skippable filler episodes ...
Caitlin Clark is back for her second season with the Fever. Here's how to keep up with all her games.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback